Screener
Insight Molecular Diagnostics Inc. IMDX Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Insight Molecular Diagnostics Inc.’s reported figures.
The source filing: Insight Molecular Diagnostics Inc.’s 10-Q, filed August 10, 2026. Open the filing →
- Filed
- Aug 10, 2026, 4:14 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001642380-26-000011
FAQ
- What is Insight Molecular Diagnostics Inc.'s free cash flow?
- Insight Molecular Diagnostics Inc. (IMDX) reported free cash flow of -$10.05M in Q2 2026.
- How has Insight Molecular Diagnostics Inc.'s free cash flow changed year-over-year?
- Insight Molecular Diagnostics Inc.'s free cash flow decreased by 54.0% year-over-year, from -$6.52M to -$10.05M.
- What is the long-term trend for Insight Molecular Diagnostics Inc.'s free cash flow?
- Over 3 years (2021 to 2025), Insight Molecular Diagnostics Inc.'s free cash flow has grown at a -12.7% compound annual growth rate (CAGR), from -$38.19M to -$25.37M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about Insight Molecular Diagnostics Inc.'s free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude